You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR FINASTERIDE; TADALAFIL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for FINASTERIDE; TADALAFIL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01139762 ↗ A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms Completed Eli Lilly and Company Phase 3 2010-09-01 The purpose of this study is to investigate the efficacy and safety of once daily tadalafil when taken with finasteride as a treatment for men with signs and symptoms of Benign Prostatic Hyperplasia and demonstrable prostate enlargement.
NCT05142254 ↗ A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study Not yet recruiting Vanderbilt University Medical Center Phase 2 2022-03-01 To conduct a randomized controlled internal pilot feasibility trial for the prevention of recurrent ischemic priapism referred to as the Priapism in Nigeria (PIN) trial. The study team will enroll a minimum of 30 participants and a maximum of 200 participants. Study investigators hypothesize that hydroxyurea therapy combined with tadalafil is superior to a combination of hydroxyurea and placebo in the prevention of recurrent ischemic priapism.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for FINASTERIDE; TADALAFIL

Condition Name

Condition Name for FINASTERIDE; TADALAFIL
Intervention Trials
Benign Prostatic Hyperplasia 1
Enlarged Prostate 1
Priapism Due to Sickle Cell Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for FINASTERIDE; TADALAFIL
Intervention Trials
Anemia, Sickle Cell 1
Prostatic Hyperplasia 1
Lower Urinary Tract Symptoms 1
Hyperplasia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for FINASTERIDE; TADALAFIL

Trials by Country

Trials by Country for FINASTERIDE; TADALAFIL
Location Trials
Canada 4
United States 4
Belgium 1
Germany 1
Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for FINASTERIDE; TADALAFIL
Location Trials
Texas 1
Louisiana 1
Florida 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for FINASTERIDE; TADALAFIL

Clinical Trial Phase

Clinical Trial Phase for FINASTERIDE; TADALAFIL
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for FINASTERIDE; TADALAFIL
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FINASTERIDE; TADALAFIL

Sponsor Name

Sponsor Name for FINASTERIDE; TADALAFIL
Sponsor Trials
Eli Lilly and Company 1
Vanderbilt University Medical Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for FINASTERIDE; TADALAFIL
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.